HK71486A - Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease - Google Patents
Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac diseaseInfo
- Publication number
- HK71486A HK71486A HK714/86A HK71486A HK71486A HK 71486 A HK71486 A HK 71486A HK 714/86 A HK714/86 A HK 714/86A HK 71486 A HK71486 A HK 71486A HK 71486 A HK71486 A HK 71486A
- Authority
- HK
- Hong Kong
- Prior art keywords
- derivatives
- disease
- treatment
- chronic obstructive
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7810946A SE7810946L (sv) | 1978-10-20 | 1978-10-20 | Metod att behandla kronisk obstruktiv luftvegssjukdom |
Publications (1)
Publication Number | Publication Date |
---|---|
HK71486A true HK71486A (en) | 1986-10-03 |
Family
ID=20336144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK714/86A HK71486A (en) | 1978-10-20 | 1986-09-25 | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease |
Country Status (8)
Country | Link |
---|---|
US (2) | US4325956A (xx) |
EP (2) | EP0011609B2 (xx) |
JP (1) | JPS5557517A (xx) |
AU (1) | AU529805B2 (xx) |
HK (1) | HK71486A (xx) |
IE (1) | IE49623B1 (xx) |
SE (1) | SE7810946L (xx) |
SG (1) | SG32486G (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
SE8002910L (sv) * | 1980-04-18 | 1981-10-19 | Draco Ab | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
US4562194A (en) * | 1984-07-31 | 1985-12-31 | Warner-Lambert Company | Synergistic non-steroidal anti-inflammatory compounds and compositions thereof |
SE8602887D0 (sv) * | 1986-06-27 | 1986-06-27 | Draco Ab | New chemical method |
IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
EP0407651A3 (en) * | 1989-07-10 | 1991-08-07 | J. Uriach & Cia. S.A. | Use of 1,3-diisobutyl-8-methylxanthine as a bronchodilator and antiallergy agent |
US5270316A (en) | 1989-10-20 | 1993-12-14 | Kyowa Hakko Kogyo Co., Ltd. | Condensed purine derivatives |
IL108754A0 (en) * | 1993-02-26 | 1994-06-24 | Schering Corp | 2-benzyl-polycyclic guanine derivatives and process for preparing them |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
NZ517546A (en) * | 1999-08-31 | 2003-10-31 | Univ Vanderbilt | Selective antagonists of A2B adenosine receptors |
WO2001062979A2 (en) | 2000-02-23 | 2001-08-30 | Cv Therapeutics, Inc. | Dentification of partial agonists of the a2a adenosine receptor |
CA2492855C (en) * | 2002-07-29 | 2012-09-18 | Cv Therapeutics, Inc. | Myocardial perfusion imaging using a2a receptor agonists |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
EP1802317A2 (en) * | 2004-10-20 | 2007-07-04 | Cv Therapeutics, Inc. | Use of a2a adenosine receptor agonists |
AU2007212542B2 (en) | 2006-02-03 | 2013-01-31 | Gilead Sciences, Inc. | Process for preparing an A2A-Adenosine receptor agonist and its polymorphs |
US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
MX2009002299A (es) * | 2006-09-01 | 2009-03-20 | Cv Therapeutics Inc | Metodos y composiciones para incrementar la tolerancia del paciente durante metodos de formacion de imagenes del miocardio. |
EP2066232A1 (en) * | 2006-09-29 | 2009-06-10 | Cv Therapeutics, Inc. | Methods for myocardial imaging in patients having a history of pulmonary disease |
WO2008086096A2 (en) * | 2007-01-03 | 2008-07-17 | Cv Therapeutics, Inc. | Myocardial perfusion imaging |
US20100086483A1 (en) * | 2008-09-29 | 2010-04-08 | Gilead Palo Alto, Inc. | Method of multidetector computed tomagraphy |
JP2016027279A (ja) * | 2014-07-02 | 2016-02-18 | 日本精工株式会社 | 冠型保持器及びアンギュラ玉軸受 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1245969B (de) * | 1967-08-03 | VEB Arzneimittelwerk Dresden, Radebeul | Verfahren zur Herstellung von Xanthinderivaten | |
GB683523A (en) | 1948-08-18 | 1952-12-03 | Beecham Res Lab | The manufacture of purine derivatives |
JPS53890B2 (xx) * | 1972-04-22 | 1978-01-12 | ||
GB1435916A (en) * | 1972-05-11 | 1976-05-19 | Beecham Group Ltd | Pharmaceutical weight-reducing compositions |
US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
-
1978
- 1978-10-20 SE SE7810946A patent/SE7810946L/xx not_active Application Discontinuation
-
1979
- 1979-09-28 EP EP79850091A patent/EP0011609B2/en not_active Expired
- 1979-09-28 EP EP81106977A patent/EP0045094B1/en not_active Expired
- 1979-10-05 US US06/082,402 patent/US4325956A/en not_active Expired - Lifetime
- 1979-10-17 AU AU51872/79A patent/AU529805B2/en not_active Ceased
- 1979-10-18 IE IE1988/79A patent/IE49623B1/en unknown
- 1979-10-19 JP JP13584479A patent/JPS5557517A/ja active Granted
-
1981
- 1981-06-12 US US06/273,213 patent/US4804664A/en not_active Expired - Fee Related
-
1986
- 1986-04-07 SG SG32486A patent/SG32486G/en unknown
- 1986-09-25 HK HK714/86A patent/HK71486A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US4804664A (en) | 1989-02-14 |
EP0045094B1 (en) | 1984-05-16 |
JPS6340167B2 (xx) | 1988-08-10 |
US4325956A (en) | 1982-04-20 |
SE7810946L (sv) | 1980-04-21 |
EP0045094A1 (en) | 1982-02-03 |
EP0011609B2 (en) | 1988-05-11 |
EP0011609B1 (en) | 1983-04-13 |
EP0011609A3 (en) | 1980-07-23 |
IE791988L (en) | 1980-04-20 |
AU529805B2 (en) | 1983-06-23 |
EP0011609A2 (en) | 1980-05-28 |
AU5187279A (en) | 1980-05-01 |
IE49623B1 (en) | 1985-11-13 |
JPS5557517A (en) | 1980-04-28 |
SG32486G (en) | 1989-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK71486A (en) | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease | |
ZA804180B (en) | Medicaments for the treatment of disorders in lipometabolism and their use | |
GB2199031A (en) | Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs | |
EP0004741A3 (en) | Thio etianic acid derivatives, their preparation and pharmaceutical use | |
JPS5555113A (en) | Oral administration medical tablet and its manufacture | |
DE3068803D1 (en) | The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them | |
DE3062981D1 (en) | Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives | |
AU2807689A (en) | Method for the treatment of body tissues and the administration of drugs thereto | |
NO171679C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler | |
NZ193078A (en) | Derivatives of 9-aminoalkyl-flyorene medicinal preparations | |
PT73061B (en) | Process for the preparation of new derivatives of taurina and its pharmaceutical use | |
GB2057872B (en) | Use of glycerylphosphoryl derivatives in the therapy of dislipaemia hepatitis and like pathological conditions and pharmaceutical compositions therefor | |
DE2967632D1 (en) | Use of a xanthine derivate in the manufacture of a medicament | |
ZA855399B (en) | Use of xanthine and thioxanthine derivatives for the preparation of medicaments | |
ZA891366B (en) | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmias | |
NL187299C (nl) | Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten. | |
DE2965208D1 (en) | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease | |
PH16250A (en) | Pharmaceutical composition of therapeutic value in the treatment of some shock conditions | |
GB2076399B (en) | Process for the manufacture of novel benzazole derivatives pharmaceutical preparations containing these derivatives and their use | |
EG14024A (en) | Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases | |
NZ184158A (en) | Uracil derivatives: preparation and pharmaceutical preparations | |
JPS539757A (en) | Production of taunorbicine derivatives and pharmaceutical composition for treating tumor of human | |
EP0018550A3 (en) | Use of physiologically acceptable methyl donors in preparing compositions for muscular disease treatment and compositions containing these methyl donors | |
GB2013671B (en) | Azathianaphthalene derivatives process for their manufactue pharmaceutical preparations containing them and their use | |
ZA7626B (en) | Pharmaceutical preparations for the treatment of coronary heart diseases |